Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vasomotor Symptoms Associated With Menopause”

45 trials

Showing 20 of 45 results

Early research (Phase 1)Study completedNCT01890109
What this trial is testing

Study of Erenumab (AMG 334) in Women With Hot Flashes

Who this might be right for
Vasomotor Symptoms; Hot Flashes
Amgen 103
Large-scale testing (Phase 3)Study completedNCT06206421
What this trial is testing

Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 277
Post-approval studies (Phase 4)Study completedNCT02234362
What this trial is testing

Vortioxetine for Menopausal Depression

Who this might be right for
DepressionMenopauseVasomotor Disturbance+2 more
Massachusetts General Hospital 47
Not applicableEnded earlyNCT01353963
What this trial is testing

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Who this might be right for
Major Depressive DisorderVasomotor Symptoms
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT02834312
What this trial is testing

E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

Who this might be right for
Hot Flushes
Donesta Bioscience 260
Large-scale testing (Phase 3)Study completedNCT00421031
What this trial is testing

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vasomotor Symptoms
Wyeth is now a wholly owned subsidiary of Pfizer 540
Large-scale testing (Phase 3)Study completedNCT00535288
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

Who this might be right for
Postmenopausal SymptomsMenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 946
Testing effectiveness (Phase 2)Study completedNCT05034042
What this trial is testing

Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 147
Testing effectiveness (Phase 2)Study completedNCT00314964
What this trial is testing

Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause

Who this might be right for
Hot Flashes
Pfizer 527
Not applicableStudy completedNCT02792504
What this trial is testing

Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

Who this might be right for
Severe Vasomotor Symptom Associated With Menopause
Pfizer 669
Post-approval studies (Phase 4)Study completedNCT00160173
What this trial is testing

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Who this might be right for
Postmenopausal Symptoms
ASCEND Therapeutics 221
Large-scale testing (Phase 3)Study completedNCT00369434
What this trial is testing

Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women

Who this might be right for
MenopauseVasomotor System
Wyeth is now a wholly owned subsidiary of Pfizer 450
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Large-scale testing (Phase 3)Study completedNCT05099159
What this trial is testing

Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHot Flashes
Bayer 400
Large-scale testing (Phase 3)Study completedNCT04234204
What this trial is testing

Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 302
Large-scale testing (Phase 3)Study completedNCT00560833
What this trial is testing

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)

Who this might be right for
MenopauseVasomotor Symptoms
Merck Sharp & Dohme LLC 943
Large-scale testing (Phase 3)Study completedNCT04451226
What this trial is testing

Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Not applicableStudy completedNCT05083884
What this trial is testing

A Survey About Hot Flashes in Women Going Through the Menopause

Who this might be right for
MenopauseVasomotor Symptoms
Astellas Pharma Europe Ltd. 2,176
Large-scale testing (Phase 3)Study completedNCT00234819
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Who this might be right for
Vasomotor Symptoms Associated With Menopause
Wyeth is now a wholly owned subsidiary of Pfizer 325
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation